Efficacy of invasive strategy for the management of acute myocardial infarction complicated by cardiogenic shock

American Journal of Cardiology

Volumn 83, Issue 7, 1999, Pages 989-993

  Pérez Castellano, Nicasio ^a   García, Eulogio ^a   Serrano, José A ^a   Elízaga, Jaime ^a   Soriano, Javier ^a   Abeytua, Manuel ^a   Botas, Javier ^a   Rubio, Rafael ^a   López De Sá, Esteban ^a   López Sendón, José L ^a   Delcán, Juan L ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOGENIC SHOCK; CLINICAL PROTOCOL; DISEASE CLASSIFICATION; FEMALE; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT SELECTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; EMERGENCIES; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MYOCARDIAL INFARCTION; SHOCK, CARDIOGENIC; SURVIVAL RATE;

EID: 0344959444     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(99)00002-8     Document Type: Article

References (30)

1. Johnson S.A., Scanlon P.J., Loeb H.S., Moran J.M., Pifarre R., Gunnar R.M. Treatment of cardiogenic shock in myocardial infarction by intraaortic balloon counterpulsation surgery. Am J Med. 62:1977;687-692.
2. DeWood M.A., Notske R.N., Hensley G.R., Shields J.P., O'Grady W.P., Spores J., Goldman M., Ganji J.H. Intraaortic balloon counterpulsation with and without reperfusion for myocardial infarction shock. Circulation. 61:1980;1105-1112.
3. Allen B.S., Buckberg G.D., Fontan F.M., Kirsh M.M., Popoff G. Superiority of controlled surgical reperfusion versus percutaneous transluminal coronary angioplasty in acute coronary occlusion. J Thorac Cardiovasc Surg. 105:1993;864-879.
4. Lee L., Bates E.R., Pitt B., Walton J.A., Laufer N., O'Neill W.W. Percutaneous transluminal coronary angioplasty improves survival in acute myocardial infarction complicated by cardiogenic shock. Circulation. 78:1988;1345-1351.
5. Lee L., Erbel R., Brown T.M., Laufer N., Meyer J., O'Neill W.W. Multicenter registry of angioplasty therapy of cardiogenic shock initial and long-term survival . J Am Coll Cardiol. 17:1991;599-603.
6. Hibbard M.D., Holmes D.R. Jr, Bailey K.R., Reeder G.S., Bresnahan J.F., Gersh B.J. Percutaneous transluminal coronary angioplasty in patients with cardiogenic shock. J Am Coll Cardiol. 19:1992;639-646.
7. Moosvi A.R., Khaja F., Villanueva L., Gheorghiade M., Douthat L., Goldstein S. Early revascularization improves survival in cardiogenic shock complicating acute myocardial infarction. J Am Coll Cardiol. 19:1992;907-914.
8. Bengtson J.R., Kaplan A.J., Pieper K.S., Wildermann N.M., Mark D.B., Pryor D.B., Phillips H.R. III, Califf R.M. Prognosis in cardiogenic shock after acute myocardial infarction in the interventional era. J Am Coll Cardiol. 20:1992;1482-1489.
9. Gacioch G.M., Ellis S.G., Lee L., Bates E.R., Kirsh M., Walton J.A., Topol E.J. Cardiogenic shock complicating acute myocardial infarction the use of coronary angioplasty and the integration of the new support devices into patient management . J Am Coll Cardiol. 19:1992;647-653.
10. Eltchaninoff H., Simpfendorfer C., Franco I., Raymond R.E., Casale P.N., Whitlow P.L. Early and 1-year survival rates in acute myocardial infarction complicated by cardiogenic shock a retrospective study comparing coronary angioplasty with medical treatment . Am Heart J. 130:1995;459-464.
11. Holmes D.R. Jr, Califf R.M., Van de Werf F., Berger P.B., Bates E.R., Simoons M.L., White H.D., Thompson T.D., Topol E.J. Difference in countries' use of resources and clinical outcome for patients with cardiogenic shock after myocardial infarction results from the GUSTO trial . Lancet. 349:1997;75-78.
12. Berger P.B., Holmes D.R. Jr, Stebbins A.L., Bates E.R., Califf R.M., Topol E.J. Impact of an aggressive invasive catheterization and revascularization strategy on mortality in patients with cardiogenic shock in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-I) trial. An observational study. Circulation. 96:1997;122-127.
13. Hochman J.S., Boland J., Sleeper L.A., Porway M., Brinker J., Col J., Jacobs A., Slater J., Miller D., Wasserman H., Menegus M.A., David Talley J., McKinlay S., Sanborn T., LeJemtel T. Current spectrum of cardiogenic shock and effect of early revascularization on mortality. Results of an International Registry. Circulation. 91:1995;873-881.
14. Sheridan D.J., Barer D., Tan L.B. Resources for cardiogenic shock. [letters] Lancet. 349:1997;951-952.
15. Himbert D., Juliard J.M., Steg P.G., Karrillon G.J., Aumont M.C., Gourgon R. Limits of reperfusion therapy for immediate cardiogenic shock complicating acute myocardial infarction. Am J Cardiol. 74:1994;492-494.
16. Tunstall-Pedoe H., Kuulasmaa K., Amouyel P., Arveiler D., Rajakangas A.M., Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation. 90:1994;583-612.
17. O'Neill W.W. Angioplasty therapy of cardiogenic shock are randomized trials necessary? J Am Coll Cardiol. 19:1992;915-917.
18. Marcus F.I., Friday K., McCans J., Moon T., Hahn E., Cobb L., Edwards J., Kuller L. Age-related prognosis after acute myocardial infarction (the Multicenter Diltiazem Postinfarction Trial). Am J Cardiol. 65:1990;559-566.
19. Rich M.W., Bosner M.S., Chung M.K., Shen J., McKenzie J.P. Is age an independent predictor of early and late mortality in patients with acute myocardial infarction? Am J Med. 92:1992;7-13.
20. Maggioni A.P., Maseri A., Fresco C., Franzosi M.G., Mauri F., Santoro E., Tognoni G. Age-related increase in mortality among patients with first myocardial infarctions treated with thrombolysis. The Investigators of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2). N Engl J Med. 329:1993;1442-1448.
21. Lee K.L., Woodlief L.H., Topol E.J., Weaver W.D., Betriu A., Col J., Simoons M., Aylward P., Van de Werf F., Califf R.M. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators. Circulation. 91:1995;1659-1668.
22. Stone G.W., Grines C.L., Browne K.F., Marco J., Rothbaum D., O'Keefe J., Hartzler G.O., Overlie P., Donohue B., Chelliah N., Timmis G.C., Vlietstra R., Strzelecki M., Puchrowicz-Ochocki S., O'Neill W.W. Predictors of in-hospital and 6-month outcome after acute myocardial infarction in the reperfusion era the Primary Angioplasty in Myocardial Infarction (PAMI) trial . J Am Coll Cardiol. 25:1995;370-377.
23. DeBusk R.F., Kraemer H.C., Nash E., Berger W.E., Lew H. Stepwise risk stratification soon after acute myocardial infarction. Am J Cardiol. 52:1983;1161-1166.
24. Hillis L.D., Forman S., Braunwald E. Risk stratification before thrombolytic therapy in patients with acute myocardial infarction. The Thrombolysis in Myocardial Infarction (TIMI) phase II co-investigators. J Am Coll Cardiol. 16:1990;313-315.
25. Mueller H.S., Cohen L.S., Braunwald E., Forman S., Feit F., Ross A., Schweiger M., Cabin H., Davison R., Miller D. Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction. Analyses of patient subgroups in the Thrombolysis in Myocardial Infarction (TIMI) trial, phase II. Circulation. 85:1992;1254-1264.
26. Kelly T.L., Gilpin E., Ahnve S., Henning H., Ross J. Jr. Smoking status at the time of acute myocardial infarction and subsequent prognosis. Am Heart J. 110:1985;535-541.
27. Barbash G.I., Reiner J., White H.D., Wilcox R.G., Armstrong P.W., Sadowski Z., Morris D., Aylward P., Woodlief L.H., Topol E.J. Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the "smoker's paradox" from the GUSTO-I trial, with angiographic insights. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol. 26:1995;1222-1229.
28. Gottlieb S., Boyko V., Zahger D., Balkin J., Hod H., Pelled B., Stern S., Behar S. Smoking and prognosis after acute myocardial infarction in the thrombolytic era. The Israeli Thrombolytic National Survey. J Am Coll Cardiol. 28:1996;1506-1513.
29. Zahger D., Cercek B., Cannon C.P., Jordan M., Davis V., Braunwald E., Shah P.K. How do smokers differ from nonsmokers in their response to thrombolysis? The TIMI-4 trial. Am J Cardiol. 75:1995;232-236.
30. De Chillou C., Riff P., Sadoul N., Ethevenot G., Feldmann L., Isaaz K., Simon J.P., Boursier M., Khalife K., Thisse J.Y., Aliot E. Influence of cigarette smoking on rate of reopening of the infarct-related coronary artery after myocardial infarction a multivariate analysis . J Am Coll Cardiol. 27:1996;1662-1668.